Affiris Ag Is A Clinical Stage Biotechnology Company Based In Viennaaustriaestablished In 2003The Company Is Dedicated To Developing Innovative Disease Modifying Therapiesparticularly For Neurodegenerative Diseasesits Mission Is To Enhance The Lives Of Patients With Chronic Conditions By Harnessing The Immune System To Target These Diseases The Company Specializes In Specific Active Immunotherapysait Utilizing Its Patented Affitome Technology To Optimize Immune Responses Against Harmful Protein Formsthis Approach Aims To Induce Long Lasting Immune Responsespotentially Allowing For Less Frequent Dosingaffiris Has A Robust Product Pipelinewith Candidates In Clinical Trials For Conditions Such As Atherosclerosisparkinson S Diseaseand Multiple System Atrophyas Well As Preclinical Candidates For Alzheimer S And Huntington S Diseasesthe Company Has Successfully Raised Approximately A 165 Million In Fundingsupporting Its Research And Development Efforts
